NAKA (22) LFMD (46) ALPS (57) EUDA (39) ⌘ Pro Terminal →

AirSculpt Technologies Inc. (AIRS) — RQD Stock Rating Cockpit

$1.67 +15.97% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.71

AirSculpt Technologies Inc. (AIRS) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D • SELL / AVOID Cap $120.4M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.71 (+2.68%)🧬 Dilution Drag (+1.92% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 0.5% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.6% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-4.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for AIRS)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (48/100 Composite)

🔍 WHY AIRS SCORES 48/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+14/20 pts (29% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+12/20 pts (25% of score)

FRED Regime × Technicals: 5% of 52W Range • RSI-14 at 53.3 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Dilution Drag (+1.92% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$1.62-21.6% Next Q

Q2 (-2Q)

Grade D$1.27-5.5% Next Q

Q3 (-1Q)

Grade D$1.20+39.2% Next Q

Current

Grade D$1.67-5.6% Hist 90D α

Trajectory: D (40) → D (48)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a AIRS Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While AIRS currently carries a cautious 48/100 (D) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.00) and Max Pain ($1.75) forces dealer call-delta covering toward $11.21.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $AIRS• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “AIRS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 48%NO 52%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

53.330 Oversold · 70 Hot

ALTMAN-Z SHIELDDISTRESS RISK (<1.8)

0.95>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

4 / 99-Pt Accounting

52-WEEK LASER RANGE5% OF RANGE

L: $1$1.67H: $11

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: DRQD 9 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: DRQD 19 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 20 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

2-of-3 JEV AI Jury Bearish Warning on AIRS

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (45)

-7.0% ROIC with 42.0% gross margin and 0.57% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BEARISH (40)

Altman-Z 0.95 and Piotroski 4/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

NEUTRAL (52)

19/40 institutional & smart-money positioning score with 12/20 macro alignment.

Bull Case: Why Buyers Like AIRS

✓Established market leader in Health Care with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AIRS)

✓Walkthrough of AIRS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

AIRS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -37.69%▼ DESCENDING CHANNEL

2026-10-30O $1.63H $1.75L $1.61C $1.67VOL 747.7K

RES: $4.41SUP: $0.81SMA50: $2.00SMA200: $3.12

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

AIRS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 AIRS Butterfly Map → + Track AIRS →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -15.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on AIRS today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for AIRS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for AIRS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AIRS)

Health Care Rank #384 of 1016 ⚔️ NAKA vs AIRS Full Matrix →

1. Head-to-Head Health Care Peer Comparison (AIRS vs. NAKA, LFMD, ALPS, EUDA)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, AirSculpt Technologies Inc. (AIRS) ranks #384 by composite RQD confidence (48/100, grade D) and #635 by equity capitalization ($120.4M). Within this direct 5-issuer industry benchmark cohort, AIRS leads on earnings valuation at N/A trailing P/E, while AIRS leads on capital efficiency and profitability with -7.0% ROIC and — gross margin. ALPS currently holds the highest overall quantitative score in the immediate peer group at 57/100 (D+) compared with AIRS at 48/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
AIRS ACTIVE AirSculpt Technologies Inc.	D	48/100	—	—	-7.0%	+15.97%	$120.4M	Benchmark Subject
NAKA Nakamoto Inc.	E	22/100	—	—	-31.6%	-3.51%	$126.2M	/naka-vs-airs →
LFMD LifeMD Inc.	D	46/100	—	85.7%	-26.2%	+4.04%	$111.8M	/lfmd-vs-airs →
ALPS ALPS Group Inc Ordinary Share	D+	57/100	—	—	—	-0.03%	$54.1M	/alps-vs-airs →
EUDA EUDA Health Holdings Limited	D-	39/100	—	43.9%	-35.0%	+1.31%	$46.4M	/euda-vs-airs →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001870940

In its most recent audited fiscal period (FY2025, filed 2025-12-31), AirSculpt Technologies Inc. (AIRS) reported GAAP revenue of $151.8M (-15.8% vs. FY2024 revenue of $180.3M , and -22.5% cumulative change since FY2023) , GAAP net income of -$11.7M, operating cash flow of $3.1M, and free cash flow of $692.0K (+126.0% YoY). On the balance sheet, AIRS closed FY2025 with $187.3M in total assets against $50.6M in total debt (Altman Z-Score: 0.95, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$151.8M	-$11.7M	$3.1M	$692.0K	$187.3M	$50.6M
FY2024 (FY)	2024-12-31	$180.3M	-$8.0M	$11.3M	-$2.7M	$212.8M	$65.5M
FY2023 (FY)	2023-12-31	$195.9M	-$4.2M	$24.0M	$24.0M	—	—

3. AIRS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is AIRS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, AirSculpt Technologies Inc. (NASDAQ: AIRS) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $1.67 (+15.97% 1D, market cap $120.4M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, AIRS ranks #384 in composite RQD confidence.

How does AIRS compare to NAKA and LFMD in the Health Care sector?

Within the Health Care sector (Medical/Nursing Services), AIRS carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -7.0%. By comparison, NAKA (Nakamoto Inc.) holds a E grade (22/100 RQD, P/E N/A, ROIC -31.6%, cap $126.2M) and LFMD (LifeMD Inc.) posts a D grade (46/100 RQD, P/E N/A, ROIC -26.2%, cap $111.8M). Among the 5-stock peer group, AIRS leads on earnings multiple (N/A) while AIRS leads on capital efficiency (-7.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for AIRS?

Per AIRS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001870940), AirSculpt Technologies Inc. generated $151.8M in revenue (-15.8% YoY), -$11.7M in net income, and $692.0K in free cash flow against $187.3M in total assets and $50.6M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is AIRS trading relative to its 50-day, 200-day, and 52-week technical levels?

AIRS last traded at $1.67 (+15.97% on volume of 1,548,442 shares), positioning the stock -16.50% below its 50-day simple moving average ($2.00) and -46.47% below its 200-day simple moving average ($3.12). Across its 52-week range of $1.15 to $10.68, AIRS sits at the 5.5% percentile with a 14-day RSI of 53.3 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.46 to $1.88).

AIRS Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell AIRS stock right now?

AirSculpt Technologies Inc. (AIRS) currently earns a Roarable Rating of D (Sell — SELL) with 48/100 RQD Confidence. Stretched risk/reward at current multiples (-7% return on capital) under elevated 10-year interest-rate pressure.

What is AIRS's 12-month price target and RQD AI Jury consensus?

AIRS's 12-month base price target is $1.59 (range $1.24 to $11.21), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: AIRS RQD Cockpit AIRS 12M Forecast AIRS Earnings & Move AIRS Dividends & DRIP AIRS Insiders & 13F AIRS Whale Options AIRS Profit Sankey AIRS News & Why